Skip to main content

TIMM | Nice, France | October 2019

By

TIMM Nice, France | October 2019 RZF in vitro Activity Against Phase 2 STRIVE Part A and Contemporary Nordic Clinical Candida Isolates Determined by the EUCAST Reference Method [465] Comparison of Killing Activity of Rezafungin, Anidulafungin, Caspofungin and Micafungin against Candida auris in the presence and absence of serum [534] Frequency of Paradoxical and Trailing Effects with Rezafungin, Anidulafungin, Caspofungin and Micafungin Against Candida Species [538] Rezafungin Clinical Safety and Efficacy in the Treatment of Candidemia and/or Invasive-Candidiasis: Combined Results from the…

Read More

IDWeek | Washington, D.C. | October 2019

By

IDWeek Washington, D.C. | October 2019 Potent in vitro Activity of Rezafungin (RZF) against Aspergillus Clinical Isolates Recovered from Lung Transplant Patients who have Received ≥3 Months of Triazole Prophylaxis [738] Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates: SENTRY 2018 [2115]

Read More